Development of novel PP2A activators for use in the treatment of acute myeloid leukaemia.
Org Biomol Chem
; 14(20): 4605-16, 2016 May 18.
Article
in En
| MEDLINE
| ID: mdl-27102578
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Design
/
Leukemia, Myeloid, Acute
/
Protein Phosphatase 2
/
Fingolimod Hydrochloride
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Language:
En
Journal:
Org Biomol Chem
Journal subject:
BIOQUIMICA
/
QUIMICA
Year:
2016
Document type:
Article
Affiliation country:
Australia
Country of publication:
United kingdom